Takumi Yamaji

Miyazaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Acute Esophageal Necrosis Secondary to Cyanotic Spells Associated with Unrepaired Tetralogy of Fallot.

Acute Esophageal Necrosis Secondary to Cyanotic Spells Associated with Unrepaired Tetralogy of Fallot.

Journal: International heart journal

Published: May 17, 2023

Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2V617F-induced Murine Myeloproliferative Neoplasm.

Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2V617F-induced Murine Myeloproliferative Neoplasm.

Journal: Anticancer research

Published: May 02, 2017

TET2 mutation in diffuse large B-cell lymphoma.

TET2 mutation in diffuse large B-cell lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 24, 2017

Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations.

Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations.

Journal: Annals of laboratory medicine

Published: June 20, 2016

TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.

TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: January 15, 2016

Surrounding Gastric Mucosa Findings Facilitate Diagnosis of Gastric Neoplasm as Gastric Adenoma or Early Gastric Cancer.

Surrounding Gastric Mucosa Findings Facilitate Diagnosis of Gastric Neoplasm as Gastric Adenoma or Early Gastric Cancer.

Journal: Gastroenterology research and practice

Published: June 17, 2015

Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms.

Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms.

Journal: Genomics data

Published: March 16, 2015

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator.

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator.

Journal: Blood

Published: November 15, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026